Several independent groups have reported targeted genomic editing in mammalian cells mediated by synthetic oligonucleotides. Nevertheless, the validity of data has been disputed because of experimental artefacts, inconsistent findings and low reproducibility. Here, we describe experiments designed to meet stringent criteria and completely eliminate artefactual results. In particular, by targeting cells expressing mutated enhanced green fluorescence protein (EGFP), which allow editing measurements at the protein level, and analyzing corrected clones by Southern blotting, we rigorously excluded spontaneous reversion, contamination artefacts, false-positives, or overestimation. Our findings provide unequivocal authentication that oligonucleotidemediated gene editing is a real, not artefactual, phenomenon-a vital starting point from which to develop the technology into practical applications. Gene Therapy (2009) Numerous publications report that synthetic oligonucleotides can induce small sequence changes in nuclear DNA of eukaryotic cells.
Numerous publications report that synthetic oligonucleotides can induce small sequence changes in nuclear DNA of eukaryotic cells. 1 Potential applications include introducing disease-associated mutations into cell lines or animals, functional studies of single-nucleotide polymorphisms (SNPs), and ultimately gene therapy. However, the validity of data is questioned because of real or alleged experimental artefacts and poor reproducibility. [2] [3] [4] In response, Albuquerque-Silva et al. 5 proposed four experimental conditions (below) for stringent validation of gene editing. Here, we describe the results of experiments designed to meet in full these criteria.
(i) Exclusion of spontaneous reversion: Our editing singlestranded oligonucleotide (ssODN) introduces a unique mutant genotype: the generation of three specific nucleotide changes, which incontrovertibly exclude a spontaneous reversion event. We chose to target a mutated enhanced green fluorescence protein (mEGFP) gene encoding full-length, but non-fluorescent, protein because of a single base mutation that creates a Y66S substitution in the central chromophore region. 6, 7 We designed the editing ssODN to introduce three specific base changes: two to reverse the amino acid substitution using a different triplet and the third to create a synonymous codon (T65) (Figure 1a ). Selection using restored fluorescence alone cannot exclude spontaneous reversion events, 8 but our design additionally generates a new NdeI site in the target sequence which allowed successful gene-editing to Figure 1 Gene-edited clones contain specific sequence alterations (a) Mutated EGFP contains a Tyrosine codon (TAC) to Serine codon (TCC) substitution at amino acid 66, which renders the protein nonfluorescent. The control ssODN is homologous to the mEGFP sequence, whereas the editing ssODN (5 0 -GAAGCACTGCACGCCA TATGTCAGGGT-3 0 ) contains three mismatches (red letters) that change the Serine codon (TCC) triplet back to an alternative Tyrosine codon (TAT) and add a silent mutation in the upstream Threonine codon (ACC to ACA). Thus, green fluorescence is re-established (grey shading) and a new NdeI restriction endonuclease recognition site is created (black boxes). (b) As CHO-mEGFP cells contain multiple transgene copies, both edited EGFP (edEGFP) and mEGFP alleles are present in gene-edited clones. Digestion with NdeI and the downstream enzymes MfeI (J 1 ), DraI (J 2 ) and XbaI (J 3 ) is predicted to yield diagnostic bands of the indicated sizes. A full colour version of this figure is available at the Gene Therapy journal online. be distinguished from reversion using Southern blotting for analysis.
(ii) Exclusion of contamination artefacts: These were eliminated as, before our experiments, the edited sequence did not exist in any cells or plasmids in our laboratory or elsewhere. Moreover, all three nucleotide changes were required to generate the NdeI site. (iii) Exclusion of false-positives: Clonal analysis was proposed to avoid residual ssODN in extracted cellular DNA, and thus the possibility of false positives by PCR-based detection. We interpreted this third requirement conservatively and avoided PCR-based technologies altogether by using flow cytometry for initial detection and Southern blotting for confirmation. (iv) Exclusion of overestimation: To fulfil this final criterion, we transfected Chinese Hamster Ovary (CHO) cells containing multiple copy integrations of mEGFP (CHO-mEGFP) 7 with the editing ssODN and isolated single green fluorescent cells 24 h later by fluorescence-activated cell sorting. We grew these clonal cells for over 4 weeks before extracting genomic DNA, digesting with NdeI and appropriate additional enzymes, and carrying out Southern blotting (Figure 1b) . Such early time-point analyses of cells at the protein level precludes overestimating gene editing efficiency by eliminating putative selective proliferation of rare edited cells.
Our findings unequivocally establish that synthetic single-stranded DNA oligonucleotides can reproducibly create specific genomic sequence alterations in mEGFP. Hence, Southern blots of two independently derived clones showed the expected diagnostic bands, whereas untreated Chinese Hamster Ovary (CHO)-mEGFP cells did not (Figure 2a-d) . Identical patterns of non-diagnostic bands were obtained from parental CHO-mEGFP cells and gene-edited clones, verifying that the clones were indeed of parental origin. Additionally, sequencing of gene-edited alleles recovered as bacterial plasmids confirmed the specific nucleotide changes (Figure 2e) .
Our data fully conform to the four mandatory validation criteria stipulated by Albuquerque-Silva et al. 5 We readily acknowledge many other successful demonstrations of gene editing, but these have relied on PCR-based detection strategies 6, 7, 9 or failed to exclude spontaneous reversions when using Southern blotting. 8 The strength of our study is stringently meeting all four criteria in a single investigation. Of vital importance was detection of the edited sequence by Southern blotting in genomic DNA of each clone analyzed; only gene editing can explain the three specific nucleotide sequence per well of a 6-well plate) were transfected with 4 mg ssODN and 8 ml Lipofectamine 2000 in 500 ml OptiMEM by drop-wise addition to the 1 ml serum-containing but antibiotic-free culture medium and incubated for 2 h. Single green fluorescent cells, which typically were 1-3% of the total cell population, were sorted into individual wells of a 96-well plate and grown for at least 4 weeks. Genomic DNA was extracted using Qiagen (Crawley, UK) genomic-tips 100/ G and digested overnight with restriction enzyme pairs, NdeI+MfeI (J1), DraI (J2) or XbaI (J3) (see Figure 1) . The fragments were separated by electrophoresis on 1% agarose gel (15 mg per lane) and alkaline blotted overnight onto Hybond XL membrane. Hybridization probes were prepared by PCR from the mEGFP plasmid used to establish CHO-mEGFP cells, 32 P-labelled with Ready-To-Go DNA Labelling beads and purified using illustra ProbeQuant G-50 microcolumns (GE Healthcare; Amersham, UK). The membrane was hybridized for 2 h with 50 ng probe in Rapid-hyb buffer (GE Healthcare), washed and then exposed to pre-flashed Biomax-MS film for 2-10 h at À70 1C. Oligonucleotide-directed gene editing is validated P Disterer et al alterations, not spontaneous 'reversion'. In brief, oligonucleotide-mediated gene editing is a real, not an artefactual phenomenon. We hope that this authentication will encourage more researchers to harness its potential for introducing disease-associated mutations or SNPs into cultured cells or mouse strains and, eventually, into the clinic for treating hereditary diseases caused by missense or frameshift mutations in genomic DNA. The technology is simple, but more importantly is predicted to have high safety and high fidelity. By contrast, though offering promise, the use of customized zinc-finger nucleases to create DNA double-strand breaks at selected sites and stimulate targeted genome modifications carries important concerns about off-target cleavage and genotoxicity. 10 
